Relmada Therapeutics, Inc.

Direct answer

Relmada Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RLMD.

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready...

Can you invest in Relmada Therapeutics, Inc.?

Yes. Relmada Therapeutics, Inc. trades publicly on NASDAQ as RLMD.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Relmada Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.